These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 6368032

  • 1. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D, Wedd DJ.
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [Abstract] [Full Text] [Related]

  • 2. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG, Paes DJ.
    Carcinogenesis; 1983 Mar; 4(3):347-52. PubMed ID: 6339100
    [Abstract] [Full Text] [Related]

  • 3. Mutagenicity of 2-methylacrolein, 2-ethylacrolein and 2-propylacrolein in Salmonella typhimurium TA100. A comparative study.
    Neudecker T, Eder E, Deininger C, Henschler D.
    Mutat Res; 1991 Dec; 264(4):193-6. PubMed ID: 1723498
    [Abstract] [Full Text] [Related]

  • 4. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA, Shane BS, Hajos AK, Winston GW.
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [Abstract] [Full Text] [Related]

  • 5. Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation.
    Braun R, Jäkel HP, Schöneich J.
    Mutat Res; 1984 Mar; 137(2-3):61-9. PubMed ID: 6381996
    [Abstract] [Full Text] [Related]

  • 6. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H, Seidel A, Ribeiro O, Kirkby C, Hirom P, Oesch F.
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [Abstract] [Full Text] [Related]

  • 7. Mutagenic activation of 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole(Trp-P-1) and 3-amino-1-methyl-5H-pyrido(4,3-b)indole (Trp-P-2) by primary cultures of adult rat hepatocytes: effect of Aroclor induction in vitro.
    Decloître F, Hamon G, Martin M, Thybaud-Lambay V.
    Mutat Res; 1984 Nov; 137(2-3):123-32. PubMed ID: 6433191
    [Abstract] [Full Text] [Related]

  • 8. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
    Suling WJ, Rice LS, Shannon WM.
    J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
    [Abstract] [Full Text] [Related]

  • 9. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM, Maddock MB.
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [Abstract] [Full Text] [Related]

  • 10. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C, Kuroki T, Brun G, Hautefeuille A, Camus AM, Bartsch H.
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [Abstract] [Full Text] [Related]

  • 11. The hair-dye reagent 2-(2',4'-diaminophenoxy)ethanol is mutagenic to Salmonella typhimurium.
    Venitt S, Crofton-Sleigh C, Osborne MR.
    Mutat Res; 1984 Jan; 135(1):31-47. PubMed ID: 6363911
    [Abstract] [Full Text] [Related]

  • 12. The mutagenic activity of chlorpromazine.
    Obaseiki-Ebor EE, Akerele JO.
    Mutat Res; 1988 May; 208(1):33-8. PubMed ID: 3285202
    [Abstract] [Full Text] [Related]

  • 13. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 14. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
    Alldrick AJ, Rowland IR.
    Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
    [Abstract] [Full Text] [Related]

  • 15. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J, Tinwell H, Callander RD, Kimber I, Clay P, Galloway SM, Hill RB, Greenwood SK, Gaulden ME, Ferguson MJ, Vogel E, Nivard M, Parry JM, Williamson J.
    Mutat Res; 1997 Dec 12; 396(1-2):45-64. PubMed ID: 9434859
    [Abstract] [Full Text] [Related]

  • 16. Mutagenic evaluation of trichlorfon using different assay methods with Salmonella typhimurium.
    Barrueco C, Herrera A, de la Peña E.
    Mutagenesis; 1991 Jan 12; 6(1):71-6. PubMed ID: 2038275
    [Abstract] [Full Text] [Related]

  • 17. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI, Saavedra JE, Farrelly JG, Andrews AW.
    Cancer Res; 1983 Sep 12; 43(9):4078-82. PubMed ID: 6347365
    [Abstract] [Full Text] [Related]

  • 18. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM, Yap SH, van Gemert PJ, Roelofs HM, Bos RP, Henderson PT.
    Mutat Res; 1986 Feb 12; 164(1):41-51. PubMed ID: 3512987
    [Abstract] [Full Text] [Related]

  • 19. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
    Beaune P, Lemestré-Cornet R, Kremers P, Albert A, Gielen J.
    Mutat Res; 1985 Jun 12; 156(3):139-46. PubMed ID: 3889631
    [Abstract] [Full Text] [Related]

  • 20. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF, Tang X, Edenharder R.
    Mutat Res; 2000 Dec 20; 472(1-2):1-21. PubMed ID: 11113694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.